Investigation Overview
An investigation on behalf of investors, who currently hold shares of OHR Pharmaceutical, Inc. (NASDAQ: OHRP), was announced concerning whether the takeover of OHR Pharmaceutical, Inc. is unfair to NASDAQ: OHRP stockholders. The investigation by a law firm concerns whether certain officers and directors of OHR Pharmaceutical, Inc. breached their fiduciary duties owed to NASDAQ: OHRP ...
You must register (for free) or login to view the entire investigation.